158 related articles for article (PubMed ID: 162947)
1. Technetium-99m-pyrophosphate: studies in vivo and in vitro.
Kaye M; Silverton S; Rosenthall L
J Nucl Med; 1975 Jan; 16(1):40-5. PubMed ID: 162947
[TBL] [Abstract][Full Text] [Related]
2. Distributions of several agents useful in imaging myocardial infarcts.
Bonte FJ; Parkey RW; Graham KD; Moore JG
J Nucl Med; 1975 Feb; 16(2):132-5. PubMed ID: 162951
[TBL] [Abstract][Full Text] [Related]
3. [Incorporation of radioactive calcium and technetium pyrophosphate in to bones].
Markt B; Bergmann G; Raab W; Willvonseder R
Acta Med Austriaca; 1977; 4(4-9):144-8. PubMed ID: 205073
[TBL] [Abstract][Full Text] [Related]
4. Correlations between uptake of technetium, calcium, phosphate, and mineralization in rat tibial bone repair.
Shani J; Amir D; Soskolne WA; Schwartz Z; Chisin R; Sela J
J Nucl Med; 1990 Dec; 31(12):2011-4. PubMed ID: 2266400
[TBL] [Abstract][Full Text] [Related]
5. Bone kinetics of calcium-45 and pyrophosphate labeled with technetium-96: an autoradiographic evaluation.
Guillemart A; Le Pape A; Galy G; Besnard JC
J Nucl Med; 1980 May; 21(5):466-70. PubMed ID: 6246225
[TBL] [Abstract][Full Text] [Related]
6. [Comparative animal experiments concerning the distribution of 99mTc-pyrophosphate, 99mTc-diphosphonate and 85Sr (author's transl)].
Büll U; Balser D; Frey KW
Fortschr Geb Rontgenstr Nuklearmed; 1974 Apr; 120(4):481-8. PubMed ID: 4367024
[No Abstract] [Full Text] [Related]
7. Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.
McRae J; Hambright P; Valk P; Bearden AJ
J Nucl Med; 1976 Mar; 17(3):208-11. PubMed ID: 175138
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
[TBL] [Abstract][Full Text] [Related]
9. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
Atamaniuk NP; Mechev DS
Eksp Onkol; 1985; 7(1):66-7. PubMed ID: 2983974
[TBL] [Abstract][Full Text] [Related]
10. Distribution of 99mTc-Sn diphosphonate and free 99mTc-pertechnetate in selected soft and hard tissues.
Silberstein EB; Francis MD; Tofe AJ; Slough CL
J Nucl Med; 1975 Jan; 16(1):58-61. PubMed ID: 162948
[TBL] [Abstract][Full Text] [Related]
11. Bone uptake of 99mTc-phosphate via labeled plasma protein.
Schümichen C; Seifritz R; Hoffmann G
Nuklearmedizin; 1980 Aug; 19(4):174-7. PubMed ID: 6259628
[TBL] [Abstract][Full Text] [Related]
12. Complexing of reduced technetium and tin (II) by chelating phosphate compounds. I. Chemical state of technetium.
Schümichen C; Hohloch H; Schiller A; Pohle W; Hoffmann G
Nuklearmedizin; 1979 May; 18(2):98-104. PubMed ID: 38438
[TBL] [Abstract][Full Text] [Related]
13. Observations on the mechanism of 99mTc-labeled phosphate complex uptake in metabolic bone disease.
Rosenthall L; Kaye M
Semin Nucl Med; 1976 Jan; 6(1):59-67. PubMed ID: 174229
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of localization of 99mTc-labeled pyrophosphate and tetracycline in infarcted myocardium.
Dewanjee MK; Kahn PC
J Nucl Med; 1976 Jul; 17(7):639-46. PubMed ID: 178842
[TBL] [Abstract][Full Text] [Related]
15. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.
Schümichen C; Hohloch M; Hoffmann G
Nuklearmedizin; 1979 May; 18(2):105-9. PubMed ID: 38437
[TBL] [Abstract][Full Text] [Related]
16. Uptake and biodistribution of technetium-99m-MD32P during rat tibial bone repair.
Schwartz Z; Shani J; Soskolne WA; Touma H; Amir D; Sela J
J Nucl Med; 1993 Jan; 34(1):104-8. PubMed ID: 8418249
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of various 99mTc-Sn-pyrophosphate compounds in the rat. II. In vitro studies.
Schümichen C; Mackenbrock B; Hoffmann G
Nuklearmedizin; 1977 Aug; 16(4):157-62. PubMed ID: 198752
[No Abstract] [Full Text] [Related]
18. Investigation of the metabolic acitivity of bone in rheumatoid arthritis.
Rosenspire KC; Kennedy AC; Steinbach J; Blau M; Green FA
J Rheumatol; 1980; 7(4):469-73. PubMed ID: 6252321
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of various 99mTc-Sn-pyrophosphate compounds in the rat. I. In vivo studies.
Schümichen C; Walden J; Hoffmann G
Nuklearmedizin; 1977 Jul; 16(3):100-3. PubMed ID: 197498
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of 99mTc-labeled pyrophosphate and polyphosphate in man.
Krishnamurthy GT; Huebotter RJ; Walsh CF; Taylor JR; Kehr MD; Tubis M; Blahd WH
J Nucl Med; 1975 Feb; 16(2):109-15. PubMed ID: 162949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
